Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1410-1417

  Spinetti, Gaia ^a   Specchia, Claudia ^a,b   Fortunato, Orazio ^a   Sangalli, Elena ^a   Clerici, Giacomo ^a   Caminiti, Maurizio ^a   Airoldi, Flavio ^a   Losa, Sergio ^a   Emanueli, Costanza ^c   Faglia, Ezio ^a   Madeddu, Paolo ^c  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; VASCULOTROPIN RECEPTOR 2; STROMAL CELL DERIVED FACTOR 1;

AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CELL COUNT; CELL MIGRATION; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; AMPUTATION; CELL MOTION; CLINICAL TRIAL; COMPLICATION; DIABETIC FOOT; DRUG EFFECTS; FOOT; ISCHEMIA; MIDDLE AGED; MORTALITY; PHYSIOLOGY; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; C-REACTIVE PROTEIN; CELL MOVEMENT; CHEMOKINE CXCL12; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; FOOT; HUMANS; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, CXCR4;

EID: 84899089000     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2084     Document Type: Article

References (24)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al.; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654
2. Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg 2006;32:484-490 (Pubitemid 44490321)
3. Faglia E, Clerici G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study [published correction appears in Diabetes Care 2009;32:1355]. Diabetes Care 2009;32:822-827
4. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-1724 (Pubitemid 41587452)
5. Iversen MM, Tell GS, Riise T, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care 2009;32:2193-2199
6. Izumi Y, Satterfield K, Lee S, Harkless LB, Lavery LA. Mortality of first-time amputees in diabetics: a 10-year observation. Diabetes Res Clin Pract 2009;83:126-131
7. Brownrigg JR, Davey J, Holt PJ, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia 2012;55:2906-2912
8. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994;74:64-65 (Pubitemid 24196317)
9. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006;114:688-699 (Pubitemid 44252311)
10. Morbach S, Furchert H, Gröblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care 2012;35:2021-2027
11. van Kuijk JP, Flu WJ, Welten GM, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J 2010;31:992-999
12. Mackie AR, Losordo DW. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J 2011;38:474-485
13. Fadini GP, de Kreutzenberg SV, Boscaro E, et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 2013;56:1856-1866
14. Menegazzo L, Albiero M, Millioni R, et al. Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression. FASEB J 2013;27:4355-4365
15. Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987 (Pubitemid 40814192)
16. Fadini GP, Maruyama S, Ozaki T, et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS ONE 2010;5:e11488
17. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45:1449-1457 (Pubitemid 40615617)
18. Fadini GP, Boscaro E, de Kreutzenberg S, et al. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 2010;33:1097-1102
19. Fortunato O, Spinetti G, Specchia C, Cangiano E, Valgimigli M, Madeddu P. Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction. Cardiovasc Res 2013;100:192-200
20. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
21. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I; International Society of Hematotherapy and Graft Engineering. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996;5:213-226
22. Yona S, Hayhoe R, Avraham-Davidi I. Monocyte and neutrophil isolation and migration assays. Curr Protoc Immunol 2010;Chapter 14:Unit 14.15
23. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. Hoboken, NJ, Wiley & Sons Ltd, 1980
24. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509